Category : Opposition


GSK Buys US Cancer Firm Nuvalent for $10.6bn

British drugmaker GSK acquires US cancer specialist Nuvalent for $10.6bn, adding two late-stage lung cancer treatments. The deal is GSK's biggest ever, boosting its oncology portfolio.

Page 1 of 1
Pickt mobile sticky banner — logo, tagline and CTA button